|
GTBP GT Biopharma Inc 109657 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-4,518,000.00 |
| Balance Sheet |
|
Current Assets
|
$5,788,000.00 |
|
Assets
|
$8,106,000.00 |
|
Current Liabilities
|
$2,219,000.00 |
|
Liabilities
|
$1,321,000.00 |
|
Equity
|
$3,569,000.00 |
|
Shares Out
|
44668969.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,728,000.00 |
|
Investing Cash Flow
|
$12,893,000.00 |
| Market Analysis |
Market Cap
|
$245,679,329.50 |
|
Price
|
$5.55 |
|
BVPS
|
0.08 |
|
PB
|
68.75 |
|
EPS
|
-0.12 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:31:49 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:36 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GTBP documents filed with the SEC.
GTBP Filings
Clear
